Day: October 23, 2019

MCLEAN, Va., Oct. 23, 2019 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) recently priced a new offering of Structured Pass-Through Certificates (K Certificates), which are multifamily mortgage-backed securities. The company expects to issue approximately $717 million in K Certificates (K-1513 Certificates), which are expected to settle on or about October 24, 2019.DetailsCo-Lead Managers and Joint Bookrunners: Wells Fargo Securities, LLC and Credit Suisse Securities (USA) LLCCo-Managers: J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, Nomura Securities International, Inc. and Stern Brothers & Co.Related LinksThe K-1513 Preliminary Offering Circular Supplement: http://www.freddiemac.com/mbs/data/k1513oc.pdfNAIC Preliminary AssessmentFreddie Mac Multifamily Securitization OverviewMultifamily Securities Investor Access...

VANCOUVER, British Columbia, Oct. 23, 2019 (GLOBE NEWSWIRE) — Eastern Zinc Corp. (“Eastern Zinc” or the “Company”) (CSE:EZNC | OTC:ETZCF) is pleased to report the assay results from two diamond drill holes completed in early September on its Portage Property located in the western part of the Bathurst Mining Camp (“BMC”) in New Brunswick (Figure 1). Holes PZ19-03 and PZ19-04 were designed to test the depth and strike potential 40 metres below and 400 metres to the north, respectively, of the Upper Road Zone volcanogenic massive sulphide (“VMS”) occurrence discovered by a previous operator in 2018.Highlights include:PZ19-031.3% Zn+Pb over 2.2 m including 5.6% Zn+Pb over 0.3 m1.1% Zn+Pb over 5.7 mPZ19-041.5% Zn+Pb over 5.5 m including 2.6% Zn+Pb over 1.2 m1.9% Zn+Pb over 0.5 mA summary of significant assay results from...

Press ReleaseGeneva, 23 October 2019ENR RUSSIA INVEST SA ANNOUNCES A NEW PRIVATE EQUITY INVESTMENT AND END THIRD QUARTER 2019 NET ASSET VALUE PER SHARENew private equity investment

OMAHA, Neb., Oct. 23, 2019 (GLOBE NEWSWIRE) — Werner Enterprises (NASDAQ: WERN), a premier transportation and logistics provider, is honored to announce its designation as a 2020 Military Friendly® Spouse Employer by VIQTORY Media for the fifth consecutive year.“We strive to honor our nation’s heroes and their families by providing the best career opportunities and resources to reach their greatest career potential,” said President and Chief Executive Officer Derek Leathers.This year’s annual list recognizes 106 employers that provide veterans and their spouses with employment opportunities and promote workforce development policies that acknowledge the unique challenges of military life and skills learned through those challenges.As a military-friendly employer, Werner is proud to say that military veterans and veteran spouses...

New York, NY, Oct. 23, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it is commenting on recent activity related to unauthorized third-party stock promotion materials (the “stock promotion” or “materials”) that reference the Company.  Such materials were brought to the Company’s attention by the compliance department of OTC Markets (late afternoon on Tuesday October 22, 2019).  The Company became aware of three such firms that released unauthorized materials: Beat Penny Stocks, OTC Rockstar, and Penny Picks, that released newsletters...

AGOURA HILLS, Calif., Oct. 23, 2019 (GLOBE NEWSWIRE) — Oncotelic Inc. (“Oncotelic”), a wholly owned subsidiary of Mateon Therapeutics Inc. (OTCQB:MATN) dedicated to the development of innovative treatments for cancer, announced today the publication of a peer-reviewed research article authored by Fatih Uckun MD PhD and his colleagues at Oncotelic in the Journal of Clinical Research in Pediatrics (https://asclepiusopen.com/clinical-research-in-pediatrics/volume-2-issue-1/).  The article titled “In silico Molecular Target Validation Demonstrates Transforming Growth Factor Beta 2 is Strongly Expressed in Pediatric Diffuse Intrinsic Pontine Glioma and Glioblastoma Multiforme” demonstrates the therapeutic potential of Mateon’s first-in-class RNA therapeutic OT101 for the treatment of diffuse intrinsic pontine glioma (DIPG) and...

 COMMUNIQUÉ DE PRESSELe 23 octobre 2019ENCRES DUBUIT : RÉSULTATS DU 1ER SEMESTRE 2019 :ENCRES DUBUIT (ISIN : FR0004030708, mnémo : ALDUB), le spécialiste des encres de hautes technologies, publie ce jour ses résultats pour le premier semestre 2019.Les résultats consolidés au titre du 1er semestre 2019 ont été examinés lors du Directoire qui s’est tenu le 21 octobre 2019 et arrêtés définitivement lors du Conseil de Surveillance qui s’est tenu le 22 octobre 2019.Analyse de l’activité du groupe au 30 juin 2019*Le chiffre d’affaires du groupe pour le premier semestre 2019 est supérieur de 77 mille euros au montant communiqué le 2 septembre 2019 (12,391 M€) en raison de correctifs apportés par les auditeurs locaux sur les activités du groupe en Espagne, aux Etats-Unis et en France.Le chiffre d’affaires du groupe Encres DUBUIT pour le premier...

October 23, 2019 – Atlantica Yield (NASDAQ: AY), the sustainable total return infrastructure company that owns a diversified portfolio of contracted assets in the energy and environment sectors, announced today that it will release its financial results for the third quarter of 2019 before the opening of the market on Thursday November 7, 2019. The information will be published on Atlantica’s website www.atlanticayield.com.Atlantica’s CEO, Santiago Seage and CFO, Francisco Martinez-Davis, will hold a conference call and a webcast on Thursday November 7, 2019, at 8:30 am (New York time).Additionally, the senior management team will be meeting investors in Orlando, FL at The EEI Financial Conference on November 10-12, 2019. In order to schedule a meeting with Atlantica please send an email to ir@atlanticayield.com. Please be advised that...

Financial highlights Q3 2019Orders received were EUR 285.0m (3Q18: 267.7m).Revenues were EUR 312.5m (3Q18: 282.0m).Adjusted EBIT* was EUR 44.3m (3Q18: 40.0m), translating to an EBIT* margin of 14.2% (3Q18: 14.2%).Net result was EUR 33.4m (3Q18: 26.7m).Basic earnings per share (EPS) were EUR 4.38 cents (3Q18: 3.94 cents).Cash flow from operating activities before interest and tax in the quarter was EUR 47.7m (3Q18: 31.6m).Net debt/EBITDA was x0.5 at quarter-end (2Q19: x0.6). Targeted capital structure is x2-3 net debt/EBITDA.The order book was EUR 431.9m (2Q19 459.4m and 3Q18: 510.8m).*Operating income adjusted for purchase price allocation (PPA) costs related to acquisitionsÁrni Oddur Thórdarson, CEO“We report yet another solid quarter for Marel with high revenues for a seasonal quarter, at EUR 313 million. Revenues and EBIT increased...